Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndrome-Reference-Cited by-同舟云学术

Opportunistic infections after alemtuzumab: New cases of norcardial infection and cytomegalovirus syndrome

Published:2017-02-01 Issue:6 Volume:23 Page:876-877
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Brownlee Wallace J¹,Chataway Jeremy²

Affiliation:

1. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK

2. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK/National Hospital for Neurology and Neurosurgery, London, UK

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458517693440

Reference5 articles.

1. Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis

2. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

3. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

4. Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

5. Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of Toxoplasma gondii and Borrelia burgdorferi infections in patients with multiple sclerosis in Poland;Scientific Reports;2024-05-14

2. Infectious issues of therapeutic monoclonal antibodies in multiple sclerosis and neuromyelitis optica spectrum disorders;Clinical and Experimental Neuroimmunology;2022-07-27

3. Pneumonia in Nervous System Injuries: An Analytic Review of Literature and Recommendations;Cureus;2022-06-02

4. Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management;Neurotherapeutics;2022-04

5. Monoclonal Antibodies as Neurological Therapeutics;Pharmaceuticals;2021-01-26